The purpose of this study is to measure the effect of milvexian given for approximately 2
weeks on (a) how the liver metabolizes other drugs (in this case one called midazolam), and
(b) the pharmacokinetics (the way the body absorbs, distributes, and gets rid of a drug) of
an oral contraceptive pill in healthy adult females.